학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 102건 | 목록 1~10
Academic Journal
Pradat Y; Université Paris-Saclay, CentraleSupélec, MICS lab, Gif-Sur-Yvette, France.; Viot J; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Centre Hospitalier Régional Universitaire de Besançon, Department of Medical Oncology, Besançon, France.; Yurchenko AA; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Gunbin K; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Cerbone L; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Deloger M; Gustave Roussy, Université Paris-Saclay, Bioinformatics Core Facility, Inserm US23, CNRS UMS 3655, Villejuif, France.; Grisay G; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Verlingue L; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Gustave Roussy, Early Drug Development Department (DITEP), Villejuif, France.; Scott V; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Padioleau I; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Panunzi L; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Michiels S; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.; Gustave Roussy, Department of Biostatistics and Epidemiology, Villejuif, France.; Hollebecque A; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Gustave Roussy, Early Drug Development Department (DITEP), Villejuif, France.; Jules-Clément G; Gustave Roussy, Université Paris-Saclay, Bioinformatics Core Facility, Inserm US23, CNRS UMS 3655, Villejuif, France.; Mezquita L; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Lainé A; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.; Loriot Y; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Gustave Roussy, Early Drug Development Department (DITEP), Villejuif, France.; Besse B; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Friboulet L; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; André F; Gustave Roussy, Department of Medical Oncology, Villejuif, France.; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Université Paris-Saclay, Faculty of Medicine, Kremlin-Bicêtre, France.; Cournède PH; Université Paris-Saclay, CentraleSupélec, MICS lab, Gif-Sur-Yvette, France.; Gautheret D; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.; Nikolaev SI; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Yurchenko AA; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; Pop OT; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Ighilahriz M; INSERM U976, Hôpital Saint-Louis, Paris, France.; Padioleau I; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; Rajabi F; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; Sharpe HJ; Signalling Programme, Babraham Institute, Cambridge, UK.; Poulalhon N; Service de dermatologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.; Dreno B; Department of Dermato-Oncology, CHU Nantes, Nantes Université, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, F-44000 Nantes, France.; Khammari A; Department of Dermato-Oncology, CHU Nantes, Nantes Université, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, F-44000 Nantes, France.; Delord M; Université de Paris, Hôpital Saint-Louis, Paris, France.; Department of Population Health Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.; Alberti A; Université de Paris, Hôpital Saint-Louis, Paris, France.; Soufir N; INSERM U976, Hôpital Saint-Louis, Paris, France.; Battistella M; INSERM U976, Hôpital Saint-Louis, Paris, France.; Université de Paris, Hôpital Saint-Louis, Paris, France.; Service d'anatomie pathologique, Hôpital Saint-Louis, Claude Vellefaux, Paris, France.; Mourah S; INSERM U976, Hôpital Saint-Louis, Paris, France.; Université de Paris, Hôpital Saint-Louis, Paris, France.; Département de Génomique des Tumeurs Solides, Hôpital Saint-Louis, Claude Vellefaux, Paris, France.; Bouquet F; Institut Roche, Boulogne-Billancourt, France.; Savina A; Institut Roche, Boulogne-Billancourt, France.; Besse A; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Mendez-Lopez M; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Grange F; Service de dermatologie, CHU Reims, Rue du general Koenig, Reims, France.; Service de Dermatologie, centre hospitalier de Valence, Valence, France.; Monestier S; Service de dermatologie, CHU La Timone, Marseille, France.; Mortier L; Service de dermatologie, CHU Lille, Clin Dermato Hop Huriez, Rue Michel Polonovski, Lille, France.; Meyer N; Service de dermatologie, Institut Univeristaire du Cancer et CHU de Toulouse, Hôpital Larrey, Toulouse, France.; Dutriaux C; Service de dermatologie, CHU Bordeaux, Bordeaux, France.; Robert C; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; Department of Medical Oncology, Gustave Roussy and Paris-Saclay University, Villejuif, France.; Saiag P; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, and EA 4340 'Biomarkers in Cancerology and Hemato-oncology,' UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.; Herms F; Service de dermatologie, Hôpital Saint-Louis, Paris, France.; Lambert J; Université de Paris, Hôpital Saint-Louis, Paris, France.; Service de Biostatistique et Information Médicale, Hôpital Saint-Louis, Paris, France.; de Sauvage FJ; Department of Molecular Oncology, Genentech, South San Francisco, California.; Dumaz N; INSERM U976, Hôpital Saint-Louis, Paris, France.; Flatz L; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.; Basset-Seguin N; INSERM U976, Hôpital Saint-Louis, Paris, France.; Université de Paris, Hôpital Saint-Louis, Paris, France.; Service de dermatologie, Hôpital Saint-Louis, Paris, France.; Nikolaev SI; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Carr RM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Vorobyev D; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.; Lasho T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Tolosa EJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Vedder A; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center, Tampa, FL, USA.; Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Yurcheko A; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.; Padioleau I; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.; Alver B; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, MN, USA.; Coltro G; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Safgren SL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Horn I; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; You X; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA.; Solary E; INSERM U1170 and Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.; Balasis ME; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center, Tampa, FL, USA.; Berger K; London Regional Transgenic and Gene Targeting Facility, Lawson Health Research Institute University of Western Ontario, London, ON, Canada.; Hiebert J; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Witzig T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Buradkar A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Graf T; 5TH Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Valent P; 5TH Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Mangaonkar AA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Robertson KD; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, MN, USA.; Howard MT; Department of Laboratory Medicine and Pathology, Mayo Clinic, MN, USA.; Kaufmann SH; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Pin C; London Regional Transgenic and Gene Targeting Facility, Lawson Health Research Institute University of Western Ontario, London, ON, Canada.; Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Geissler K; Sigmund Freud University Vienna, Vienna, Austria.; Droin N; INSERM U1170 and Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.; Padron E; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center, Tampa, FL, USA.; Zhang J; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA.; Nikolaev S; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France. sergey.nikolaev@gustaveroussy.fr.; Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA. patnaik.mrinal@mayo.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Padioleau, I.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어